Effect of a course of aerobic training versus control group on blood factors and psychological symptoms in patients undergoing hemodialysis

Effect of a course of aerobic training versus control group on blood factors and psychological symptoms in patients undergoing hemodialysis: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N608

Enrollment

Registered

2026-05-14

Start date

2026-05-31

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis. Encounter for adequacy testing for hemodialysis

Interventions

Intervention 1: Intervention group: Treatment and routine care for hemodialysis patients, along with aerobic exercises including pedaling on a stationary mini electric bike for 30 minutes, and resista

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 65 years, Patients undergoing hemodialysis,

Exclusion criteria

Exclusion criteria: Movement disorders

Design outcomes

Primary

Measure	Time frame
Blood calcium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood phosphorus level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood sodium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood potassium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood hemoglobin level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood hematocrit level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood platelet level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood creatinine level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood urea level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood albumin level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood triglyceride level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood cholesterol level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood alkaline phosphatase level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood SGOT level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood samp	—

Measure

Time frame

Blood calcium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood phosphorus level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood sodium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood potassium level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood hemoglobin level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood hematocrit level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood platelet level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood creatinine level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood urea level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood albumin level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood triglyceride level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood cholesterol level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood alkaline phosphatase level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood sample.;Blood SGOT level. Timepoint: Before the intervention and three months later. Method of measurement: By taking and testing a blood samp

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahimeh Ghodrati

Islamic Azad University

fahimeghoratii@gmail.com+98 66 4251 8000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026